CareCredit moves vet financing off the terminal and into Vetspire

About 85% of the more than 1,000 veterinary hospitals and clinics on Vetspire are already enrolled CareCredit providers, by the companies' own count. A partnership announced September 30th, 2026 moves that financing off the external terminal and into Vetspire's practice software. The operator payoff is one less step at the moment an owner decides whether to approve treatment.

The integration finishes a job that was mostly done

Real-time financing offers from CareCredit, the health and wellness financing brand of Synchrony, will be embedded directly in Vetspire's cloud platform instead of running through a separate terminal. The release does not say when every clinic will have it, only that Vetspire is still rolling the capability out. The release also promises practices customized marketing templates, business intelligence support and shared tools for cost conversations with clients. No financial terms were disclosed.

The new-clinic math is softer than it looks. The release cites "more than 1,000" clinics and "approximately 85%" enrollment, which leaves roughly 15%, or something on the order of 150 clinics, not yet enrolled. The release names the 15% but not a clinic count, and both inputs are rounded, so treat 150 as our estimate.

The footprint figure also moved fast. When Vetspire announced its Battery Ventures investment on August 13th, 2026, it said its software was in use at more than 800 pet hospitals and clinics. Seven weeks later the floor is more than 1,000, and 85% of that floor alone is about 850 enrolled clinics. Both are minimums rather than counts, so the gap may be a rounding choice, but neither release explains it.

"This partnership reflects CareCredit's continued focus on modernizing the veterinary care and payment experience through innovation, integration and smarter technology," said Jonathan Wainberg, Senior Vice President and General Manager, Pet, Synchrony.

Ownership explains the timing better than the technology

Embedding the card in clinic software is familiar ground for CareCredit. Practices on IDEXX's Cornerstone, ezyVet and Neo systems can already process CareCredit transactions and find client accounts directly within their practice software. Vetspire joins that list rather than starting it.

What changed is who owns Vetspire. The platform left Thrive Pet Healthcare and took a growth investment from Battery Ventures in August, naming Zachary Seely chief executive. Thrive has no ownership going forward but remains a customer, according to Vetspire's company-reported August release.

Under Thrive, the preferred lender was someone else. In 2022 the consolidator turned Scratch, already its primary client financing option for two years, into a formal multi-year partner, with Scratch committing to integrated offerings across Thrive's practice management systems such as Vetspire. Whether that contract still runs is not public. We could be wrong, but a CareCredit integration landing seven weeks after the spin-out reads like a platform picking partners for its whole customer base rather than one parent's hospitals. That is our interpretation. Neither company draws the connection.

The stakes sit at the treatment decision. A PetSmart Charities and Gallup survey of 2,498 US dog and cat owners, fielded from November 2024 to January 2025, found 52% had skipped or declined needed veterinary care in the past year. Among that group, 71% cited cost as the key factor.

Lenders that stay outside the software lose the moment

Rival lenders start from different places. Sunbit already reaches at least one veterinary system, after Shepherd Veterinary Software embedded its pay-over-time product directly in the practice workflow. Scratch, Thrive's 2022 partner, now pitches the opposite design, a checkout built to work alongside practice software without requiring a PIMS integration.

Our view is that if approvals increasingly happen inside practice software, terminal-first lenders sit a step removed from the conversation that decides the sale. The companies say they plan to gather and share clinic-level performance data as the rollout continues. That would be public evidence on whether in-workflow financing lifts treatment acceptance, though it will be company-reported.

Until it arrives, this is distribution, not proof.

Source: CareCredit via PR Newswire